Top Markets
Coin of the day
Seaport Therapeutics, Inc. Common Stock Seaport Therapeutics, Inc. Common Stock

Seaport Therapeutics, Inc. Common Stock

SPTX
Rang in Aktien #8294
Seaport Therapeutics, Inc. is a developing biopharmaceutical enterprise... Seaport Therapeutics, Inc. is a developing biopharmaceutical enterprise currently undergoing clinical trials, focused on creating groundbreaking treatments for neuropsychiatric conditions. The company is primarily engaged in tackling disorders like depression and anxiety, utilizing its unique Glyph technology. This exclusive platform is engineered to allow for oral administration of drugs, circumventing initial metabolic processing in the liver, and thereby reducing the risk of liver enzyme elevations, hepatotoxicity, and other potential adverse reactions. Every therapeutic agent in their pipeline incorporates this advanced platform, with all research and development efforts exclusively dedicated to neuropsychiatric applications. Founded in 2024 and situated in Boston, Massachusetts, the company connects with medical professionals and influential experts across the healthcare and neuropsychiatric sectors.
Aktienkurs
$24.37
Marktkapitalisierung
$1.30B
Veränderung (1 Tag)
-7.16%
Veränderung (1 Jahr)
-
Land
US
Handel Seaport Therapeutics, Inc. Common Stock (SPTX)

Kategorie

Kursverlauf für Seaport Therapeutics, Inc. Common Stock (SPTX)
Höchster Schlusskurs: $24.31 am 2026-08-01

Niedrigster Schlusskurs: $16.84 am 2026-05-01
Kursverlauf der Aktie von Seaport Therapeutics, Inc. Common Stock von 2026 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
Nicht genügend Daten für die angegebenen Daten.
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
$542.09 38.27%
US
$1.03K 45.80%
NL
$121.53 -12.48%
AU
$138.18 464.67%
US
$759.27 6.90%
CH